AU526539B2 - 2-(3,4-disubstituted-phenylimino)-imidazolidines - Google Patents

2-(3,4-disubstituted-phenylimino)-imidazolidines

Info

Publication number
AU526539B2
AU526539B2 AU53893/79A AU5389379A AU526539B2 AU 526539 B2 AU526539 B2 AU 526539B2 AU 53893/79 A AU53893/79 A AU 53893/79A AU 5389379 A AU5389379 A AU 5389379A AU 526539 B2 AU526539 B2 AU 526539B2
Authority
AU
Australia
Prior art keywords
fluoro
formula
acid
compound
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU53893/79A
Other languages
English (en)
Other versions
AU5389379A (en
Inventor
Herbert Koppe
Werner Kummer
Helmut Stahle
Alexander Walland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
C.H. Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.H. Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH filed Critical C.H. Boehringer Sohn AG and Co KG
Publication of AU5389379A publication Critical patent/AU5389379A/en
Application granted granted Critical
Publication of AU526539B2 publication Critical patent/AU526539B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU53893/79A 1978-12-18 1979-12-17 2-(3,4-disubstituted-phenylimino)-imidazolidines Ceased AU526539B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE28546590 1978-12-18
DE19782854659 DE2854659A1 (de) 1978-12-18 1978-12-18 Neue 3,4-disubstituierte 2-phenylimino-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
AU5389379A AU5389379A (en) 1980-06-26
AU526539B2 true AU526539B2 (en) 1983-01-20

Family

ID=6057553

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53893/79A Ceased AU526539B2 (en) 1978-12-18 1979-12-17 2-(3,4-disubstituted-phenylimino)-imidazolidines

Country Status (18)

Country Link
EP (1) EP0012822B1 (enExample)
JP (1) JPS5583754A (enExample)
AT (1) ATE1903T1 (enExample)
AU (1) AU526539B2 (enExample)
CA (1) CA1112648A (enExample)
DE (2) DE2854659A1 (enExample)
DK (1) DK146821C (enExample)
ES (3) ES8102100A1 (enExample)
FI (1) FI68814C (enExample)
GR (1) GR73913B (enExample)
IE (1) IE49239B1 (enExample)
IL (1) IL58971A (enExample)
NO (1) NO148555C (enExample)
NZ (1) NZ192426A (enExample)
PH (1) PH22130A (enExample)
PT (1) PT70592A (enExample)
YU (1) YU41901B (enExample)
ZA (1) ZA796832B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2933930A1 (de) * 1979-08-22 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim 2-(2-chlor-4-cyclopropyl-phenylimino)-imidazolidin, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben.
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
AU704972B2 (en) 1994-08-04 1999-05-13 H. Lundbeck A/S Novel benzimidazole derivatives
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
PE28099A1 (es) * 1996-11-25 1999-03-31 Procter & Gamble Proceso para hacer derivados de 2-amino-2-imidazolina, guanidina y 2-amino-3,4,5,6-tetrahidropirimidina
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
US6066740A (en) * 1997-11-25 2000-05-23 The Procter & Gamble Company Process for making 2-amino-2-imidazoline, guanidine and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
CN111303038A (zh) * 2020-03-18 2020-06-19 滨州德润化工有限责任公司 一种油田水处理用缓蚀剂两性咪唑啉制作工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123037C (enExample) * 1963-10-04
BE687656A (enExample) * 1965-10-01 1967-03-30
DE1545628A1 (de) * 1965-10-01 1970-06-25 Boehringer Sohn Ingelheim Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2)
AT278775B (de) * 1967-01-19 1970-02-10 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Δ<2>-Imidazolinderivaten und ihren Salzen
AT330769B (de) * 1974-04-05 1976-07-26 Chemie Linz Ag Verfahren zur herstellung von 2-arylamino- 2-imidazolin-derivaten und ihren salzen
DE2806775A1 (de) * 1978-02-17 1979-08-30 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben

Also Published As

Publication number Publication date
DE2964166D1 (en) 1983-01-05
JPH0118071B2 (enExample) 1989-04-03
YU41901B (en) 1988-02-29
NZ192426A (en) 1984-07-06
CA1112648A (en) 1981-11-17
IE49239B1 (en) 1985-09-04
FI793948A7 (fi) 1980-06-19
DK146821C (da) 1984-06-25
DK146821B (da) 1984-01-16
ES486967A0 (es) 1981-02-16
ES8100272A1 (es) 1980-11-01
ES486970A0 (es) 1980-12-16
IL58971A (en) 1984-03-30
EP0012822A1 (de) 1980-07-09
JPS5583754A (en) 1980-06-24
NO148555C (no) 1983-11-23
PT70592A (de) 1980-01-01
AU5389379A (en) 1980-06-26
YU308979A (en) 1983-04-30
DE2854659A1 (de) 1980-07-10
ATE1903T1 (de) 1982-12-15
ES8102100A1 (es) 1980-12-16
FI68814C (fi) 1985-11-11
ZA796832B (en) 1981-08-26
IL58971A0 (en) 1980-03-31
FI68814B (fi) 1985-07-31
ES8103054A1 (es) 1981-02-16
DK537179A (da) 1980-06-19
NO148555B (no) 1983-07-25
ES486971A0 (es) 1980-11-01
PH22130A (en) 1988-06-01
EP0012822B1 (de) 1982-12-01
NO794114L (no) 1980-06-19
IE792447L (en) 1980-06-18
GR73913B (enExample) 1984-05-22

Similar Documents

Publication Publication Date Title
AU5389379A (en) 2-(3,4-disubstituted-phenylimino)-imidazolidines
DE2960481D1 (en) Compositions and process for regulating plant growth
BR8603787A (pt) Compostos heterociclicos,e,processo de sua preparacao e aplicacao
AU549688B2 (en) Esters of n-alkyl substituted amino methyl phosphonic acids
KR870003055A (ko) 살충성 화합물
CA1273347C (enExample)
ES8102110A1 (es) Procedimiento para la preparacion de acido 1,2,3-tiadiazol- 5-il-tioglicolico
ES443472A1 (es) Un procedimiento para la preparacion de nuevas tidiazolili- midazolinas.
DK161599C (da) Fremgangsmaade til fremstilling af lysergsyreestere
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona